| 1 |
Synergistic Anti-tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer |
|
| | Ragini Singh, Shuang Cheng, Qinghua Zeng, Santosh Kumar, Carlos Marques | | | Livers. 2022; 2(4): 344 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo |
|
| | Lu Yang,Jiaxi Xu,Zheng Xie,Faquan Song,Xin Wang,Rupei Tang | | | Asian Journal of Pharmaceutical Sciences. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells |
|
| | Seo Yun Moon,Heejin Lee,Seoree Kim,Ji Hyung Hong,Sang Hoon Chun,Hee Yeon Lee,Keunsoo Kang,Ho Shik Kim,Hye Sung Won,Yoon Ho Ko | | | BMC Cancer. 2021; 21(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion |
|
| | Veronica S. Hughes,Dietmar W. Siemann | | | Oncotarget. 2019; 10(2): 184 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Effects of Lidocaine and Src Inhibition on Metastasis in a Murine Model of Breast Cancer Surgery |
|
| | Thomas P. Wall,Peter D. Crowley,Aislinn Sherwin,Andrew G. Foley,Donal J. Buggy | | | Cancers. 2019; 11(10): 1414 | | | [Pubmed] [Google Scholar] [DOI] | |
|
